These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Adjuvant therapies in advanced hepatocellular carcinoma: moving forward from the STORM.
    Author: Bouattour M, Soubrane O, de Gramont A, Faivre S.
    Journal: Trials; 2016 Nov 25; 17(1):563. PubMed ID: 27887632.
    Abstract:
    UNLABELLED: Like other previous treatments and approaches, sorafenib, an antiangiogenic drug, failed to show any benefit in the adjuvant setting for hepatocellular carcinoma in a large clinical trial. We discuss reasons and implications of these negative results and the implications for clinical practice and future research. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00692770 . Registered 5 June 2008. This study has been completed.
    [Abstract] [Full Text] [Related] [New Search]